REG - Oxford Biomedica PLC - Block Listing Return
RNS Number : 9927POxford Biomedica PLC01 June 2018
For Immediate Release
1 June 2018
OXFORD BIOMEDICA PLC
BLOCK LISTING RETURN
Name of applicant:
OXFORD BIOMEDICA PLC
Name of scheme:
2015 Employee Share Option Scheme
Period of return:
From:
31 December 2017
To:
31 May 2018
Balance of unallotted securities under scheme(s) from previous return:
15,696,647 (pre 1:50 share consolidation)
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
NIL
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
2,056,185 (pre 1:50 share consolidation)
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
272,809 (post 1:50 share consolidation)
Name of applicant:
OXFORD BIOMEDICA PLC
Name of scheme:
2015 Long Term Incentive Plan
Period of return:
From:
31 December 2017
To:
31 May 2018
Balance of unallotted securities under scheme(s) from previous return:
27,237,496 (pre 1:50 share consolidation)
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
NIL
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
300,000 (pre 1:50 share consolidation)
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
538,749 (post 1:50 share consolidation)
Name of applicant:
OXFORD BIOMEDICA PLC
Name of scheme:
2015 Deferred Bonus Plan
Period of return:
From:
31 December 2017
To:
31 May 2018
Balance of unallotted securities under scheme(s) from previous return:
8,509,245 (pre 1:50 share consolidation)
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
NIL
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
646,074 (pre 1:50 share consolidation)
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
157,263 (post 1:50 share consolidation)
Name of contact:
Stuart Paynter
Telephone number of contact:
01865 783000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDBLRFBMPTMBTMMMP
Recent news on Oxford BioMedica
See all newsREG - Oxford Biomedica PLC - Preliminary results for the year ended 31 Dec 2025
AnnouncementRCS - Oxford Biomedica PLC - Licensing agreement with VVMF
AnnouncementREG - Stock Exch Notice - Admission to Trading - 09/03/2026
AnnouncementREG - Oxford Biomedica PLC - Admission to Trading
AnnouncementREG - Oxford Biomedica PLC - Admission to Trading Application
Announcement